Artificial heart research
This article was originally published in The Gray Sheet
Executive Summary
National Heart, Lung, and Blood Institute awards three contracts for development of a total artificial heart and for evaluation of its compatibility with body tissues. Three teams -- Abiomed and the Texas Heart Institute; Nimbus, Inc. and the Cleveland Clinic Foundation; and Pennsylvania State University and Sarns/3M Health Care -- will each receive between $5 mil. and $6 mil. over a three-year Phase I period. The University of Utah, one of the NHLBI developers until now ("The Gray Sheet, May 25, 1992, I&W-8), did not receive additional funding. NHLBI says the two most promising artificial hearts will be selected to proceed to Phase II, for which funding would range between $8 mil. and $9 mil. over four years.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.